# A Study of TAK-951 in Healthy Adults

> **NCT04486950** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** TAK-951
- **DRUG:** TAK-951 Placebo

## Key facts

- **NCT ID:** NCT04486950
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-07
- **Primary completion:** 2021-05-16
- **Final completion:** 2021-05-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486950, "A Study of TAK-951 in Healthy Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04486950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*